- Entry
- $43.34
- Now
- $41.70 -3.8%
- Target
- —
- Score
- —
On 3 August the CEO, Mike Mahoney, bought 186,240 shares on the open market at about $48. That's roughly $9M of his own money. Three directors bought in the same few weeks. These weren't plan trades or option exercises. Plain open-market purchases. People sell stock for a dozen reasons, but they generally buy it for one. Worth saying they're already underwater. The stock is about 10% below where he paid. What actually happened to BSX this year? I know the …
— ORIGINAL POST ·
Boston Scientific peaked at $105 last November. It closed yesterday at $43.55
· r/stocks
· Sep 18, 2026